Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1996-04-01
1998-11-10
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514212, 514217, 514218, 514220, 514255, 514320, 514325, 540484, 540547, 540557, 540575, 540587, 540596, 540609, 544375, 544381, 546196, 546203, 546204, A61K 3155, C07D26720, C07D41304, C07D41704
Patent
active
058344594
ABSTRACT:
Described herein are D4 receptor-selective compounds of the general formula: ##STR1## wherein: A and B are independently selected, optionally substituted, unsaturated 5- or 6-membered, homo- or heterocyclic rings;
REFERENCES:
patent: 3458516 (1969-07-01), Howell et al.
patent: 3501483 (1970-03-01), Howell et al.
patent: 3546226 (1970-12-01), Schmutz
patent: 5229382 (1993-07-01), Chakrabarti et al.
patent: 5286722 (1994-02-01), Cairns et al.
patent: 5393752 (1995-02-01), Liegeois et al.
patent: 5602121 (1997-02-01), Fu
patent: 5602124 (1997-02-01), Tehim et al.
patent: 5605897 (1997-02-01), Beasley, Jr. et al.
The Merck Manual, Fifteenth Edition, (1987), Berkow, M.D., Editor-in-chief, pp. 2486-2487.
Allelix Biopharmaceuticals Inc.
Rao Deepak R.
Raymond Richard L.
LandOfFree
Alkyl-substituted compounds having dopamine receptor affinity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alkyl-substituted compounds having dopamine receptor affinity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkyl-substituted compounds having dopamine receptor affinity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1516903